Gamma Knife radiosurgery (GKRS) is an established treatment for vestibular schwannoma, but contemporary cohort-level data integrating long-term tumor control with clinical symptom trajectories and hearing-related correlates remain valuable.
When counseling vestibular schwannoma patients considering Gamma Knife radiosurgery, audiologists and neurotologists should present long-term symptom trajectory data—not just tumor control rates—because hearing preservation outcomes vary and some symptom patterns worsen over time despite local control.
Moving beyond binary tumor-control reporting toward symptom trajectory analysis gives clinicians and patients a more complete picture of quality-of-life outcomes after radiosurgery for vestibular schwannoma.
- 01Cohort study tracked long-term tumor control and symptom trajectories post-Gamma Knife radiosurgery for vestibular schwannoma.
- 02Hearing outcomes after radiosurgery were variable; tumor control does not guarantee hearing preservation.
- 03Symptom trajectories (tinnitus, dizziness, balance) followed distinct patterns over the follow-up period.
- 04Findings support incorporating symptom-trajectory counseling alongside tumor-control statistics in shared decision-making.
- 05Published in Journal of Neuro-Oncology (PMID 42334723).
Contemporary Gamma Knife radiosurgery achieves high rates of long-term tumor control for vestibular schwannoma.
studysupportedHearing outcomes after Gamma Knife radiosurgery for vestibular schwannoma are variable and do not uniformly follow tumor control status.
studysupportedSymptom trajectories (tinnitus, dizziness) follow distinct patterns following radiosurgery independent of tumor control.
studypartially supported- PMID
- 42334723
- DOI
- 10.1007/s11060-026-05682-5.
- Journal
- Journal of Neuro-Oncology
- Publication type
- research_article
- Evidence level
- 4
- Population
- Patients with vestibular schwannoma treated with contemporary Gamma Knife radiosurgery
- Intervention
- Gamma Knife stereotactic radiosurgery for vestibular schwannoma
Primary outcomes
Long-term tumor control rate; Hearing outcomes post-radiosurgery; Symptom trajectory (tinnitus, vertigo, balance) over follow-up